GSA Capital Partners LLP bought a new stake in shares of Proto Labs, Inc. (NYSE:PRLB – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 17,852 shares of the industrial products company’s stock, valued at approximately $524,000.
Other hedge funds also recently added to or reduced their stakes in the company. Canada Pension Plan Investment Board purchased a new stake in Proto Labs during the 2nd quarter valued at about $37,000. Innealta Capital LLC purchased a new stake in Proto Labs during the 2nd quarter valued at about $40,000. Meeder Asset Management Inc. purchased a new stake in Proto Labs during the 2nd quarter valued at about $80,000. Shell Asset Management Co. purchased a new stake in Proto Labs during the 1st quarter valued at about $132,000. Finally, Diversified Trust Co grew its stake in Proto Labs by 9.2% during the 2nd quarter. Diversified Trust Co now owns 8,431 shares of the industrial products company’s stock valued at $260,000 after purchasing an additional 707 shares during the last quarter. 84.54% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In other Proto Labs news, CEO Robert Bodor purchased 3,480 shares of Proto Labs stock in a transaction that occurred on Friday, September 6th. The stock was bought at an average price of $28.68 per share, with a total value of $99,806.40. Following the acquisition, the chief executive officer now owns 80,878 shares of the company’s stock, valued at $2,319,581.04. This trade represents a 4.50 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 1.20% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
Read Our Latest Stock Analysis on PRLB
Proto Labs Stock Down 0.7 %
Shares of PRLB opened at $37.01 on Wednesday. Proto Labs, Inc. has a 52 week low of $25.75 and a 52 week high of $41.87. The company has a market capitalization of $907.12 million, a price-to-earnings ratio of 39.37 and a beta of 1.32. The stock’s 50-day moving average price is $30.95 and its 200-day moving average price is $30.99.
Proto Labs (NYSE:PRLB – Get Free Report) last released its quarterly earnings results on Friday, November 1st. The industrial products company reported $0.47 earnings per share for the quarter, topping analysts’ consensus estimates of $0.32 by $0.15. The company had revenue of $125.60 million during the quarter, compared to analysts’ expectations of $121.38 million. Proto Labs had a return on equity of 3.49% and a net margin of 4.76%. Proto Labs’s quarterly revenue was down 3.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.31 EPS. As a group, equities analysts anticipate that Proto Labs, Inc. will post 0.84 EPS for the current fiscal year.
Proto Labs Profile
Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.
Read More
- Five stocks we like better than Proto Labs
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- 5 discounted opportunities for dividend growth investors
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- 3 Best Fintech Stocks for a Portfolio Boost
- 3 Hot Stock Trends to Ride Into 2025
Want to see what other hedge funds are holding PRLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Proto Labs, Inc. (NYSE:PRLB – Free Report).
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.